14 Works
Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive multiple sclerosis of Black or African American and European ancestry
Darin T Okuda, Thomas Stanley, Morgan McCreary, Alexander Smith, Andrew Wilson, Marco C Pinho, Fang F Yu, Thibo Billiet, Wim Van Hecke, Annemie Ribbens, Burcu Zeydan, Orhun Kantarci, Xiaohu Guo & Tatum M Moog
Background:We evaluated imaging features suggestive of neurodegeneration within the brainstem and upper cervical spinal cord (UCSC) in non-progressive multiple sclerosis (MS).Methods:Standardized 3-Tesla three-dimensional brain magnetic resonance imaging (MRI) studies were prospectively acquired. Rates of change in volume, surface texture, curvature were quantified at the pons and medulla-UCSC. Whole and regional brain volumes and T2-weighted lesion volumes were also quantified. Independent regression models were constructed to evaluate differences between those of Black or African ancestry (B/AA)...
Ethnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage study
Hayley J Denison, Marine Corbin, Jeroen Douwes, Stephanie G Thompson, Matire Harwood, Alan Davis, John N Fink, P Alan Barber, John H Gommans, Dominique A Cadilhac, William Levack, Harry McNaughton, Joosup Kim, Valery L Feigin, Virginia Abernethy, Jackie Girvan, Andrew Wilson & Anna Ranta
Background:Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed.Aims:This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors.Methods:This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for...
Ethnic differences in stroke outcomes in Aotearoa New Zealand: A national linkage study
Hayley J Denison, Marine Corbin, Jeroen Douwes, Stephanie G Thompson, Matire Harwood, Alan Davis, John N Fink, P Alan Barber, John H Gommans, Dominique A Cadilhac, William Levack, Harry McNaughton, Joosup Kim, Valery L Feigin, Virginia Abernethy, Jackie Girvan, Andrew Wilson & Anna Ranta
Background:Ethnic differences in post-stroke outcomes have been largely attributed to biological and socioeconomic characteristics resulting in differential risk factor profiles and stroke subtypes, but evidence is mixed.Aims:This study assessed ethnic differences in stroke outcome and service access in New Zealand (NZ) and explored underlying causes in addition to traditional risk factors.Methods:This national cohort study used routinely collected health and social data to compare post-stroke outcomes between NZ Europeans, Māori, Pacific Peoples, and Asians, adjusting for...
A phase III, multi-arm multi-stage covariate-adjusted response-adaptive randomized trial to determine optimal early mobility training after stroke (AVERT DOSE)
Julie Bernhardt, Leonid Churilov, Helen Dewey, Geoffrey Donnan, Fiona Ellery, Coralie English, Lan Gao, Kathryn Hayward, Frances Horgan, Bent Indredavik, Hannah Johns, Peter Langhorne, Richard Lindley, Sheila Martins, Md Ali Katijjahbe, Sandy Middleton, Marj Moodie, Jeyaraj Pandian, Brooke Parsons, Thompson Robinson, Velandai Srikanth & Vincent Thijs
Rationale:The evidence base for acute post-stroke rehabilitation is inadequate and global guideline recommendations vary.Aim:To define optimal early mobility intervention regimens for ischemic stroke patients of mild and moderate severity.Hypotheses:Compared with a prespecified reference arm, the optimal dose regimen(s) will result in more participants experiencing little or no disability (mRS 0–2) at 3 months post-stroke (primary), fewer deaths at 3 months, fewer and less severe complications during the intervention period, faster recovery of unassisted walking, and...
Selective vulnerability of brainstem and cervical spinal cord regions in people with non-progressive multiple sclerosis of Black or African American and European ancestry
Darin T Okuda, Thomas Stanley, Morgan McCreary, Alexander Smith, Andrew Wilson, Marco C Pinho, Fang F Yu, Thibo Billiet, Wim Van Hecke, Annemie Ribbens, Burcu Zeydan, Orhun Kantarci, Xiaohu Guo & Tatum M Moog
Background:We evaluated imaging features suggestive of neurodegeneration within the brainstem and upper cervical spinal cord (UCSC) in non-progressive multiple sclerosis (MS).Methods:Standardized 3-Tesla three-dimensional brain magnetic resonance imaging (MRI) studies were prospectively acquired. Rates of change in volume, surface texture, curvature were quantified at the pons and medulla-UCSC. Whole and regional brain volumes and T2-weighted lesion volumes were also quantified. Independent regression models were constructed to evaluate differences between those of Black or African ancestry (B/AA)...
Translation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing following stroke across Europe (QASC Europe): A pre-test/post-test implementation study
Sandy Middleton, Simeon Dale, Benjamin McElduff, Kelly Coughlan, Elizabeth McInnes, Robert Mikulik, Thomas Fischer, Jan Van der Merwe, Dominique Cadilhac, Catherine D’Este, Christopher Levi, Jeremy M Grimshaw, Andreea Grecu, Clare Quinn, Ngai Wah Cheung, Tereza Koláčná, Sabina Medukhanova, Estela Sanjuan Menendez, Susana Salselas, Gert Messchendorp, Anne-Kathrin Cassier-Woidasky, Marcelina Skrzypek-Czerko, Merce Slavat-Plana, Urso Antonella & Waltraud Pfeilschifter
Introduction:Poor adoption of stroke guidelines is a problem internationally. The Quality in Acute Stroke Care (QASC) trial demonstrated significant reduction in death and disability with facilitated implementation of nurse-initiatedMethods:This was a multi-country, multi-centre, pre-test/post-test study (2017–2021) comparing post implementation data with historically collected pre-implementation data. Hospital clinical champions, supported by the Angels Initiative conducted multidisciplinary workshops discussing pre-implementation medical record audit results, barriers and facilitators to FeSS Protocol implementation, developed action plans and provided education,...
Transient Polycomb activity represses developmental genes in growing oocytes
Ellen G. Jarred, Zhipeng Qu, Tesha Tsai, Ruby Oberin, Sigrid Petautschnig, Heidi Bildsoe, Stephen Pederson, Qing-hua Zhang, Jessica M. Stringer, John Carroll, David K. Gardner, Maarten Van den Buuse, Natalie A. Sims, William T. Gibson, David L. Adelson & Patrick S. Western
Abstract Background Non-genetic disease inheritance and offspring phenotype are substantially influenced by germline epigenetic programming, including genomic imprinting. Loss of Polycomb Repressive Complex 2 (PRC2) function in oocytes causes non-genetically inherited effects on offspring, including embryonic growth restriction followed by post-natal offspring overgrowth. While PRC2-dependent non-canonical imprinting is likely to contribute, less is known about germline epigenetic programming of non-imprinted genes during oocyte growth. In addition, de novo germline mutations in genes encoding PRC2 lead...
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Jessica Howell, Amit Samani, Binish Mannan, Saur Hajiev, Leila Motedayen Aval, Rebecca Abdelmalak, Vincent C. Tam, Dominik Bettinger, Robert Thimme, Tamar H. Taddei, David E. Kaplan, Max Seidensticker & Rohini Sharma
Background:The impact of nonalcoholic fatty liver disease (NAFLD) on overall survival (OS), treatment response and toxicity in patients with hepatocellular carcinoma (HCC) treated with sorafenib is unknown. We examined the impact of NAFLD on survival and toxicity in an international cohort of patients receiving sorafenib.Methods:Clinical and demographic data were collected from patients consecutively treated at specialist centres in Europe and North America. The impact of NAFLD on OS, sorafenib-specific survival and toxicity compared with other...
Translation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing following stroke across Europe (QASC Europe): A pre-test/post-test implementation study
Sandy Middleton, Simeon Dale, Benjamin McElduff, Kelly Coughlan, Elizabeth McInnes, Robert Mikulik, Thomas Fischer, Jan Van der Merwe, Dominique Cadilhac, Catherine D’Este, Christopher Levi, Jeremy M Grimshaw, Andreea Grecu, Clare Quinn, Ngai Wah Cheung, Tereza Koláčná, Sabina Medukhanova, Estela Sanjuan Menendez, Susana Salselas, Gert Messchendorp, Anne-Kathrin Cassier-Woidasky, Marcelina Skrzypek-Czerko, Merce Slavat-Plana, Urso Antonella & Waltraud Pfeilschifter
Introduction:Poor adoption of stroke guidelines is a problem internationally. The Quality in Acute Stroke Care (QASC) trial demonstrated significant reduction in death and disability with facilitated implementation of nurse-initiatedMethods:This was a multi-country, multi-centre, pre-test/post-test study (2017–2021) comparing post implementation data with historically collected pre-implementation data. Hospital clinical champions, supported by the Angels Initiative conducted multidisciplinary workshops discussing pre-implementation medical record audit results, barriers and facilitators to FeSS Protocol implementation, developed action plans and provided education,...
A phase III, multi-arm multi-stage covariate-adjusted response-adaptive randomized trial to determine optimal early mobility training after stroke (AVERT DOSE)
Julie Bernhardt, Leonid Churilov, Helen Dewey, Geoffrey Donnan, Fiona Ellery, Coralie English, Lan Gao, Kathryn Hayward, Frances Horgan, Bent Indredavik, Hannah Johns, Peter Langhorne, Richard Lindley, Sheila Martins, Md Ali Katijjahbe, Sandy Middleton, Marj Moodie, Jeyaraj Pandian, Brooke Parsons, Thompson Robinson, Velandai Srikanth & Vincent Thijs
Rationale:The evidence base for acute post-stroke rehabilitation is inadequate and global guideline recommendations vary.Aim:To define optimal early mobility intervention regimens for ischemic stroke patients of mild and moderate severity.Hypotheses:Compared with a prespecified reference arm, the optimal dose regimen(s) will result in more participants experiencing little or no disability (mRS 0–2) at 3 months post-stroke (primary), fewer deaths at 3 months, fewer and less severe complications during the intervention period, faster recovery of unassisted walking, and...
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
Jessica L. Fairley, Dylan Hansen, Laura Ross, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jennifer Walker, Lauren V. Host, Kathleen Morrisroe, Diane Apostolopoulous, Nava Ferdowsi, Michelle Wilson, Maryam Tabesh, Wendy Stevens & Mandana Nikpour
Abstract Objectives To describe the clinical phenotype and prognosis of people in the Australian Scleroderma (SSc) Cohort Study with pulmonary arterial hypertension (PAH) with or without interstitial lung disease (ILD). Methods Participants meeting ACR/EULAR criteria for SSc were divided into four mutually exclusive groups: those meeting criteria for PAH (PAH-only), ILD (ILD-only), concurrent PAH and ILD (PAH-ILD) or neither PAH nor ILD (SSc-only). Logistic or linear regression analyses were used for associations between clinical features,...
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study
Jessica Howell, Amit Samani, Binish Mannan, Saur Hajiev, Leila Motedayen Aval, Rebecca Abdelmalak, Vincent C. Tam, Dominik Bettinger, Robert Thimme, Tamar H. Taddei, David E. Kaplan, Max Seidensticker & Rohini Sharma
Background:The impact of nonalcoholic fatty liver disease (NAFLD) on overall survival (OS), treatment response and toxicity in patients with hepatocellular carcinoma (HCC) treated with sorafenib is unknown. We examined the impact of NAFLD on survival and toxicity in an international cohort of patients receiving sorafenib.Methods:Clinical and demographic data were collected from patients consecutively treated at specialist centres in Europe and North America. The impact of NAFLD on OS, sorafenib-specific survival and toxicity compared with other...
Transient Polycomb activity represses developmental genes in growing oocytes
Ellen G. Jarred, Zhipeng Qu, Tesha Tsai, Ruby Oberin, Sigrid Petautschnig, Heidi Bildsoe, Stephen Pederson, Qing-hua Zhang, Jessica M. Stringer, John Carroll, David K. Gardner, Maarten Van den Buuse, Natalie A. Sims, William T. Gibson, David L. Adelson & Patrick S. Western
Abstract Background Non-genetic disease inheritance and offspring phenotype are substantially influenced by germline epigenetic programming, including genomic imprinting. Loss of Polycomb Repressive Complex 2 (PRC2) function in oocytes causes non-genetically inherited effects on offspring, including embryonic growth restriction followed by post-natal offspring overgrowth. While PRC2-dependent non-canonical imprinting is likely to contribute, less is known about germline epigenetic programming of non-imprinted genes during oocyte growth. In addition, de novo germline mutations in genes encoding PRC2 lead...
Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
Jessica L. Fairley, Dylan Hansen, Laura Ross, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jennifer Walker, Lauren V. Host, Kathleen Morrisroe, Diane Apostolopoulous, Nava Ferdowsi, Michelle Wilson, Maryam Tabesh, Wendy Stevens & Mandana Nikpour
Abstract Objectives To describe the clinical phenotype and prognosis of people in the Australian Scleroderma (SSc) Cohort Study with pulmonary arterial hypertension (PAH) with or without interstitial lung disease (ILD). Methods Participants meeting ACR/EULAR criteria for SSc were divided into four mutually exclusive groups: those meeting criteria for PAH (PAH-only), ILD (ILD-only), concurrent PAH and ILD (PAH-ILD) or neither PAH nor ILD (SSc-only). Logistic or linear regression analyses were used for associations between clinical features,...